Stephanie L. Rayner
Stanford University(US)Macquarie University(AU)
Publications by Year
Research Areas
Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Autophagy in Disease and Therapy, Ubiquitin and proteasome pathways, Genetic Neurodegenerative Diseases
Most-Cited Works
- → CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia(2016)207 cited
- → The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia(2015)102 cited
- → Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD(2019)86 cited
- → Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis(2020)75 cited
- → Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype(2017)50 cited
- → Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy(2017)50 cited
- → TDP-43 as a therapeutic target in neurodegenerative diseases: Focusing on motor neuron disease and frontotemporal dementia(2023)39 cited
- → Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer(2017)38 cited
- → Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype(2018)37 cited
- → Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF (cyclin F) complex(2017)30 cited